$0.3699
0.01995.69%
Last update: Nov 4, 4:00 AM
Actuate Therapeutics Inc
ACTUNASDAQ
The average analyst price target for Actuate Therapeutics is $13.67, 3696.2% above the current price. Of 3 analysts, 3 rate it Buy. Targets range from $6 to $20. The latest change came on Jul 30, 2026, when Rodman & Renshaw initiated coverage of Actuate Therapeutics with a Buy rating and a $6 price target.
Price Target Range — 5 Quarters
Analyst Consensus — 3 Analysts
Rating Trend — Last 9 Months
